Your browser doesn't support javascript.
loading
Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus Prednisone.
Efstathiou, Eleni; Davis, John W; Pisters, Louis; Li, Weimin; Wen, Sijin; McMullin, Ryan P; Gormley, Michael; Ricci, Deborah; Titus, Mark; Hoang, Anh; Zurita, Amado J; Tran, NamPhuong; Peng, Weimin; Kheoh, Thian; Molina, Arturo; Troncoso, Patricia; Logothetis, Christopher J.
Afiliación
  • Efstathiou E; Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of GU Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. Electronic address: eefstathiou@mdanderson.org.
  • Davis JW; Division of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pisters L; Division of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Li W; Janssen Research & Development, Spring House, PA, USA.
  • Wen S; Department of Biostatistics, West Virginia University School of Public Health, Morgantown, WV, USA.
  • McMullin RP; LabConnect LLC, Seattle, WA, USA.
  • Gormley M; Janssen Research & Development, Spring House, PA, USA.
  • Ricci D; Janssen Research & Development, Raritan, NJ, USA.
  • Titus M; Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of GU Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hoang A; Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of GU Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zurita AJ; Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of GU Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tran N; Clinical Research & Development, Janssen Research & Development, Los Angeles, CA, USA.
  • Peng W; Clinical Research & Development, Janssen Research & Development, Los Angeles, CA, USA.
  • Kheoh T; Department of Biostatistics & Programming, Janssen Research & Development, San Diego, CA, USA.
  • Molina A; Oncology Science Innovation, Janssen Research & Development, Menlo Park, CA, USA.
  • Troncoso P; Division of Pathology and Laboratory Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Logothetis CJ; Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of GU Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Eur Urol ; 76(4): 418-424, 2019 10.
Article en En | MEDLINE | ID: mdl-31176622
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Prednisona / Hormona Liberadora de Gonadotropina / Acetato de Abiraterona / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Prednisona / Hormona Liberadora de Gonadotropina / Acetato de Abiraterona / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Año: 2019 Tipo del documento: Article